Page URL:

The UK's HTA to regulate the collection of cord blood stem cells

6 May 2008
Appeared in BioNews 456

The UK's Human Tissue Authority (HTA) has announced that the collection of umbilical cord blood stem cells is to be regulated for the first time in the UK. Cord blood contains a rich source of stem cells that could be used to fight disease and may in the future be used in regenerative medicine. The regulation forms part of the European Union Tissue and Cells Directive, which was transposed into UK law via the Human Tissue (Quality and Safety for Human Application) Regulations in 2007.

As of 5 July 2008, only licensed premises will be allowed to procure cord blood for either public or private use, a move that seeks to ensure the collection process is facilitated by qualified staff trained to collect samples of the highest quality. In addition, those acting under the licence will be required to implement procedures that do not detract attention away from the mother and baby at the time of collection and operate a fully traceable system for any cells they procure for treatment purposes. The licence has been dubbed 'a badge of honour' by the HTA.

The requirement for the collection process to be carried out exclusively by trained professionals places a ban on unqualified parties such as fathers and birth partners from collecting the cells on behalf of the mother, which has been suggested as an option by some private companies who sell collection kits to expectant families. Private companies currently rely on the good will of midwives to collect on their behalf, but they may not have received any formal training for this type of procedure.

The Times newspaper reports that the new regulation has triggered a row between the HTA and Virgin Health Bank (VHB), who operate a public and private banking facility, with VHB declaring that the authority has been hasty in its decision and that thousands of parents would be denied the opportunity to collect their cells. However, Andrew McNeil, Chief Executive of the HTA said, 'We have heard that fathers, who of course have no experience in collecting cord blood, may be involved in the procedure. The result is that the best samples may not be collected'. He added: 'The worry is that if inexperienced people are involved, it will not be done at the right time and in the right way. We are introducing this regulation to make sure that the best quality samples are taken in the safest way'.

The new regulations have been welcomed by the Royal College of Obstetricians and Gynaecologists (RCOG), who in its scientific opinion paper published June 2006 called for greater control of the collection process and management of the third stage of labour. Professor Peter Braude, chair of the RCOG's expert committee on cord blood banking commented that 'we are pleased that the procurement of umbilical cells will now be regulated by the HTA in the pursuit of quality.

Ban on fathers collecting stem-cell blood at birth
The Times |  05/08
Rules for cord blood collection
BBC News Online |  30 April 2008
Training for cord blood collection
Nursing Times |  30 April 2008
Use of DIY stem cell blood kits curbed
The Independent |  05/08
13 June 2011 - by Nishat Hyder 
A Glaswegian company has recently launched a new stem cell banking service which offers adults the opportunity to bank stem cells using a newly approved method of extraction and isolation...
28 September 2009 - by MacKenna Roberts 
Banking a newborn's umbilical cord blood through a private company so that stem cells may be derived and stored for that child's or sibling's future medical uses is not financially worthwhile, according to a study performed at the University of California San Francisco (UCSF). It found that the chances of privately stored umbilical cord blood being therapeutic in the next twenty years are so remote that it does not justify the expense. The researchers calculated that it costs ap...
6 April 2009 - by Sarah Pritchard 
Some UK National Health Service (NHS) hospitals are banning the collection of umbilical cord blood at birth unless it goes into a public blood bank rather than being stored for future use by the individual. King's College hospital in London and Watford General hospital in Hertfordshire have...
15 September 2008 - by Dr Karen Devine 
The UK's Antony Nolan Bone Marrow Trust this week launched a new initiative - the Antony Nolan Cord Blood Bank and a combined stem cell research centre at Nottingham Trent University. Mothers who deliver babies at the Kings College Hospital, London, are being recruited to donate the stem...
4 August 2008 - by Dr Karen Devine 
The UK's Human Tissue Authority (HTA) has announced the launch of a consultation programme on a new code of practice for the storage of human tissue. This is the first code of practice to apply to the storage of tissue specifically for research purposes and includes stem...
5 February 2007 - by Khadija Ibrahim 
Sir Richard Branson has launched a new company under his Virgin brand which will offer umbilical cord blood banking facilities to parents of newborn babies. Cord blood transfusions are already used for the treatment of blood related disorders but some believe that umbilical cord blood, which is...
11 November 2006 - by Heidi Nicholl 
Scientists from Newcastle University have managed to grow the world's first miniature artificial liver in the laboratory. The team, led by Dr Nico Forraz and Professor Colin McGuckin, used NASA technology to make the piece of tissue, the size of a one penny piece, from donated umbilical...
20 October 2006 - by Dr Karen Devine 
Once again, umbilical cord blood (UCB) stem cell collection and storage has been in the headlines of the popular press. UCB can be collected at birth and stored for the future use of the donor, its siblings or donated for public use. There are two main types of banking - public...
15 June 2006 - by Dr Karen Devine 
This week saw the long awaited report from the Royal College of Obstetricians and Gynaecologists (RCOG), which stated its latest position on the public and private banking of umbilical cord blood stem cells. Essentially, their stance remains unchanged from the one taken in their previous opinion paper published in 2001...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.